T 0493/09 (Hepatits C/MERCK SHARP & DOHME CORP.) of 27.02.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T049309.20130227
- Date of decision
- 27 February 2013
- Case number
- T 0493/09
- Petition for review of
- -
- Application number
- 96936938.8
- IPC class
- A61K 38/19A61K 38/18A61K 38/21
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Continuous low-dose cytokine infusion therapy
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- Sandoz AG
Krauss, Jan B. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Violation of the right to be heard (no)
Late submissions - admitted (no)
Main request: amendments - allowable (yes); novelty (no) - Catchword
- -
- Citing cases
- T 2025/23
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.
3. The request of appellant I for reimbursement of the appeal fee is rejected.